Fig. 2From: Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancera Median (95% CI) pre-RT baseline TLCs (X 103/µl), b Slope of median (95% CI) TLCs reduction over time (X 103/µl per day), c Median (95% CI) lowest TLCs (X 103/µl), and d Median (95% CI) time to lowest TLCs (days) in patients treated with CFRT/CMT, SBRT/CMT, and SBRT/NFVBack to article page